JBS N.V. Reports $45.5 Billion Revenue, Net Income Declines 87.4% in First Half of 2026

JBS N.V. reported a net revenue of $45.5 billion for the six-month period ending June 30, 2026, marking a 12.3% increase from $40.5 billion in the same period of 2025. However, the company experienced a significant decline in net income, which fell to $145.4 million from $1.15 billion year-over-year, representing an 87.4% decrease. The gross profit also decreased by 10% to $4.91 billion, attributed to a 15.8% rise in the cost of sales, which reached $40.6 billion, primarily driven by increased costs of raw materials and livestock.

In terms of operational performance, JBS's Adjusted EBITDA decreased to $2.56 billion from $3.28 billion, reflecting a 21.9% decline. The company noted that the increase in average sales prices by 10.4% and a slight rise in sales volumes of 1.7% across all segments contributed positively to revenue growth. However, the rising costs of inventories and production inputs, particularly cattle prices, significantly impacted profitability.

Strategically, JBS has been active in expanding its operations and enhancing its market position. The company announced a joint venture with PT Danantara Investment Management to focus on protein production in Indonesia and other Southeast Asian markets. Additionally, JBS has transitioned to filing SEC reports as a U.S. domestic company, which is expected to streamline its regulatory compliance. The company also completed the early extinguishment of certain debt instruments, incurring financial expenses of $171.6 million, which included write-offs and premiums related to the early redemption of senior notes.

Geographically, JBS continues to maintain a strong presence in the global protein market, with the United States accounting for 50% of its net revenue, followed by Brazil at 27%. The company serves over 330,000 customers across approximately 197 countries. Despite the challenges posed by geopolitical tensions and rising commodity prices, JBS remains committed to its growth strategy, focusing on operational efficiencies and market expansion. The outlook for the remainder of 2026 suggests continued monitoring of market conditions and potential adjustments to its operational strategies to mitigate risks associated with fluctuating costs and economic uncertainties.